The 2017 Off-Label Regulatory Compliance Congress will explore the current regulatory landscape and provide a better understanding of how the industry can work with officials to disseminate scientific information capable of advancing public health. This preeminent event will also deliver the necessary guidance needed to ensure that your promotional practices remain compliant.
Through engaging and collaborative panels, industry leaders will take on rulings of recent court cases, the themes developed during the FDA’s public hearing, the 21st Century Cures Act and much more. This is a must-attend event for every pharmaceutical and medical device professional with responsibilities in regulatory affairs, compliance and/or promotion.
Through engaging and collaborative panels, industry leaders will take on rulings of recent court cases, the themes developed during the FDA’s public hearing, the 21st Century Cures Act and much more. This is a must-attend event for every pharmaceutical and medical device professional with responsibilities in regulatory affairs, compliance and/or promotion.
